Article Details

The world's biggest asset manager is taking a stake in a fast-growing Oxford-based AI drug ...

Retrieved on: 2021-03-03 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

The world's biggest asset manager is taking a stake in a fast-growing Oxford-based AI drug .... View article details on hiswai:

Excerpt

William Abecassis, head of BlackRock's Innovation Capital arm, said Exscientia was "breaking ground in small molecule drug design, with a platform that ...

Article found on: news.sky.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo